Immunic investor relations
Witryna3 lis 2024 · Immunic expressly disclaims all liability in respect to actions taken or not taken based on any or all the contents of this press release. Contact Information. … Witryna3 lis 2024 · Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected] US IR Contact Rx …
Immunic investor relations
Did you know?
Witryna3 kwi 2024 · Investor Home. Avadel Pharmaceuticals plc (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. Our current lead … Witryna6 lis 2024 · Immunic, Inc. (NASDAQ:NASDAQ:IMUX) Q3 2024 Earnings Conference Call November 3, 2024 8:00 AM ETCompany ParticipantsJessica Breu - Head, IR and …
Witryna12 kwi 2024 · For Institutional Investors, Securities Analysts. Phone line：+81-3-3244-3022. Business hours (JST): From Monday to Thursday: 8:45 am to 5:45 pm, Friday: 8:45 am to 4:00 pm (closed on Saturdays, Sundays, national holidays and company holidays) WitrynaManager Investor Relations and Communications Immunic AG. 2 Jahre und 6 Monate, Mai 2016 - Okt. 2024. Junior Consultant Public and Investor Relations MC Services AG. 1 Jahr und 2 Monate, März …
Witryna10 paź 2024 · Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected] US IR Contact Rx … WitrynaSEC Filings. Select the filing type and date range you wish to view from the drop-down menus below. An annual report to security holders. Open An annual report to security holders. in HTML. Open An annual report to security holders. in DOC file. Open An annual report to security holders. in PDF file.
WitrynaInvestor updates. Past IR events View all events. Investors. 2024 Credit Suisse Global Healthcare Conference. Read more. Investors. ... Investor relations team contacts. Genentech. Genentech has been delivering on the promise of biotechnology for over 35 years. Discover more. Contact. Locations.
Witryna3 mar 2024 · We disclaim any obligation to supplement or update the information in these press releases. Year. 2024. March 27, 2024. Incyte Announces Japanese Approval of Pemazyre® (pemigatinib) for the Treatment of Patients with Myeloid/Lymphoid Neoplasms (MLNs) March 23, 2024. Incyte Provides Regulatory Update on Ruxolitinib … flow properties calculatorWitryna1 kwi 2024 · SAN DIEGO , March 14, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that the Company will present a quantitative systems pharmacology (QSP) model for predicting the effects of the investigational enzyme replacement therapy pegtibatinase, in classical … green cleaning products sealWitryna25 kwi 2024 · Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune ... flow proof mathWitryna2 lut 2024 · Immunic expressly disclaims all liability in respect to actions taken or not taken based on any or all the contents of this press release. Contact Information Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected] US IR Contact Rx Communications Group Paula … green cleaning service salemWitrynaNeuroBo Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing innovative treatments for chronic liver and related metabolic diseases. NeuroBo has clinical programs targeting non-alcoholic steatohepatitis (NASH), obesity, and Type 2 diabetes. Our strategic partner and the largest shareholder, Dong-A ST … flow proof geometry definitionWitryna26 lut 2024 · /PRNewswire/ -- Immunic, Inc. (Nasdaq: ... Head of Investor Relations and Communications +49 89 2080 477 09 [email protected] US IR Contact Rx … green cleaning services connecticutWitryna14 lip 2024 · NEW YORK, July 14, 2024 /PRNewswire/ -- Immunic, Inc. (the "Company") (Nasdaq: IMUX ), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies ... green cleaning products walmart